Transderm Scop (Novatris Consumer Health, Inc.)


Welcome to the PulseAid listing for the Transderm Scop drug offered from Novatris Consumer Health, Inc.. This Anticholinergic [EPC],Cholinergic Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Novatris Consumer Health, Inc.
NON-PROPRIETARY NAME: scopolamine
SUBSTANCE NAME: SCOPOLAMINE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Anticholinergic [EPC],Cholinergic Antagonists [MoA]
ROUTE: TRANSDERMAL
DOSAGE FORM: PATCH, EXTENDED RELEASE
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2007-10-02
END MARKETING DATE: 0000-00-00


Transderm Scop HUMAN PRESCRIPTION DRUG Details:

Item DescriptionTransderm Scop from Novatris Consumer Health, Inc.
LABELER NAME: Novatris Consumer Health, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 1(mg/3d)
START MARKETING DATE: 2007-10-02
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0067-4345_99ea3737-e82b-44eb-b125-b20e43e5044d
PRODUCT NDC: 0067-4345
APPLICATION NUMBER: NDA017874

Other SCOPOLAMINE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Baxter Healthcare CorporationTransderm Scop
Novatris Consumer Health, Inc.Transderm Scop
Perrigo New York IncScopolamine Trandermal System
Physicians Total Care, Inc.Transderm Scop
Sandoz IncTransderm Scop